SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Restructurings
An SI Board Since September 2002
Posts SubjectMarks Bans
270 25 0
Emcee:  rkrw Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
120LJPC -- 40% >>SAN DIEGO, March 30 /PRNewswire-FirstCall/ -- La Jolla Phartuck-3/31/2005
119xcyte just hired chris henney. which i don't think argues for it going intokeokalani'nui-3/23/2005
118XCYT -- 24% -- not suggesting inclusion in the portfolio (except maybe for histotuck-3/23/2005
117Isis 40 % Isis Pharmaceuticals to Slash Work Force Monday January 10, 7:39 am EIcebrg-1/10/2005
116Corixa selling Bexxar rights; slashing 42 percent of staff [Some more from the Icebrg-12/14/2004
115Inex (IEX.TO) 63 %. Inex to cut 103 jobs, reduce expenses Tue Dec 14, 2004 08:4Icebrg-12/14/2004
114Corixa (CRXA) 43%: Message 20853635 Cheers, Tucktuck-12/13/2004
113>>Maxim Pharm announces restructuring, will cut 50% of workforce (MAXM) &ltuck-10/18/2004
112SQNM, ~25%. Message 20358534 Current employee base is about 200, per Yahoo!, stuck-7/29/2004
111Avigen says to cut 39 percent of work force Thursday July 15, 8:51 am ET NEW YMike McFarland-7/15/2004
110cers; 6/30/04; 35%; $2.39 Press Release Source: Cerus Corporation Cerus Increrkrw-7/2/2004
109looks like the fish went bye-bye. good move. yet another biotech, heavy on bioscaram(o)uche-6/30/2004
1086/30/04; 11%, $10/share Press Release Source: Exelixis, Inc. Exelixis Restrucrkrw-6/30/2004
107Rick, I was NOT suggesting Genta is a buy!!!! I'd add a now very shaky dealrkrw-5/13/2004
106Yeah, but... it's a one-trick pony, it's a Rosenwald company, and the scaram(o)uche-5/13/2004
105For what it's worth, a contrarian strategy of buying in at the restructuringrkrw-5/13/2004
104GNTA 5/13 45% Press Release Source: Genta Incorporated Genta Announces Restrurkrw-5/13/2004
103I think that sets a new standard. A 3rd downsizing!rkrw-3/17/2004
102LYNX another 15% >>HAYWARD, Calif., March 17 /PRNewswire-FirstCall/ -- Lytuck-3/17/2004
101Active Biotech, 44%... Active Biotech Focuses Operations on Development Projectnigel bates-3/1/2004
100[INCY 57%] Message 19761151 I was hoping they might be able to sell their genotuck-2/2/2004
99Zeltia (not quite sure what %)... PharmaMar Business Review Day Meeting with Annigel bates-1/28/2004
98Caliper again, 12%: Message 19564433nigel bates-12/5/2003
97Corixa, 18%... SEATTLE--(BUSINESS WIRE)--Nov. 6, 2003--Corixa Corp. (Nasdaq:CRXnigel bates-11/6/2003
96GPC Biotech, 21% MARTINSRIED/MUNICH, Germany, and U.S. Research Facilities in nigel bates-10/9/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News